The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system

Fehr, 2015, Coronaviruses: an overview of their replication and pathogenesis, Methods Mol. Biol., 1282, 1, 10.1007/978-1-4939-2438-7_1 Peiris, 2003, The severe acute respiratory syndrome, N. Engl. J. Med., 349, 2431, 10.1056/NEJMra032498 Zaki, 2012, Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia, N. Engl. J. Med., 367, 1814, 10.1056/NEJMoa1211721 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Liu, 2020, The reproductive number of COVID-19 is higher compared to SARS coronavirus, J. Travel Med., 27, 10.1093/jtm/taaa021 Lauer, 2020, The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application, Ann. Intern. Med., 10.7326/M20-0504 Tisoncik, 2012, Into the eye of the cytokine storm, Microbiol. Mol. Biol. Rev., 76, 16, 10.1128/MMBR.05015-11 Ferrara, 1993, Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1, Transplant. Proc., 25, 1216 Yuen, 2005, Human infection by avian influenza A H5N1, Hong Kong Med. J., 11, 189 Guan, 2020, COVID-19, Clinical Characteristics of Coronavirus Disease 2019 in China, N. Engl. J. Med., 10.1056/NEJMoa2002032 Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir. Med., 8, 420, 10.1016/S2213-2600(20)30076-X Bhatia, 2012, Role of chemokines in the pathogenesis of acute lung injury, Am. J. Respir. Cell Mol. Biol., 46, 566, 10.1165/rcmb.2011-0392TR Channappanavar, 2017, Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology, Semin. Immunopathol., 39, 529, 10.1007/s00281-017-0629-x Zhang, 2020, The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality, Int. J. Antimicrob. Agents, 10.1016/j.ijantimicag.2020.105954 Cameron, 2008, Human immunopathogenesis of severe acute respiratory syndrome (SARS), Virus Res., 133, 13, 10.1016/j.virusres.2007.02.014 Williams, 2014, The mercurial nature of neutrophils: still an enigma in ARDS?, Am. J. Physiol. Lung Cell Mol. Physiol., 306, L217, 10.1152/ajplung.00311.2013 Friedman, 2008, Clinical uses of interferons, Br. J. Clin. Pharmacol., 65, 158, 10.1111/j.1365-2125.2007.03055.x Borden, 2007, Interferons at age 50: past, current and future impact on biomedicine, Nat. Rev. Drug Discov., 6, 975, 10.1038/nrd2422 Carswell, 1975, An endotoxin-induced serum factor that causes necrosis of tumors, Proc. Natl. Acad. Sci. U. S. A., 72, 3666, 10.1073/pnas.72.9.3666 Hamilton, 2008, Colony-stimulating factors in inflammation and autoimmunity, Nat. Rev. Immunol., 8, 533, 10.1038/nri2356 Brocker, 2010, Evolutionary divergence and functions of the human interleukin (IL) gene family, Hum. Genomics, 5, 30, 10.1186/1479-7364-5-1-30 Scheller, 2006, Interleukin-6 and its receptor: from bench to bedside, Med. Microbiol. Immunol., 195, 173, 10.1007/s00430-006-0019-9 Hunter, 2015, IL-6 as a keystone cytokine in health and disease, Nat. Immunol., 16, 448, 10.1038/ni.3153 Kimura, 2010, IL-6: regulator of Treg/Th17 balance, Eur. J. Immunol., 40, 1830, 10.1002/eji.201040391 Chen, 2020, [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia], Zhonghua Jie He He Hu Xi Za Zhi, 43, E005 McGonagle, 2020, The role of cytokines including Interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease, Autoimmun. Rev., 10.1016/j.autrev.2020.102537 Henry, 2020, Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis, Clin. Chem. Lab. Med., 10.1515/cclm-2020-0369 Ulhaq, 2020, Interleukin-6 as a potential biomarker of COVID-19 progression, Med. Mal. Infect., 10.1016/j.medmal.2020.04.002 DeDiego, 2014, Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival, J. Virol., 88, 913, 10.1128/JVI.02576-13 Rotondi, 2018, Role of chemokines in thyroid cancermicroenvironment: is CXCL8 the main player?, Front. Endocrinol. (Lausanne), 10.3389/fendo.2018.00314 Rotondi, 2007, Role of chemokines in endocrine autoimmune diseases, Endocr. Rev., 28, 492, 10.1210/er.2006-0044 Sozzani, 2000, Chemokine receptors: interaction with HIV-1 and viral-encoded chemokines, Pharm. Acta Helv., 74, 305, 10.1016/S0031-6865(99)00040-0 Zemans, 2009, Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury, Am. J. Respir. Cell Mol. Biol., 40, 519, 10.1165/rcmb.2008-0348TR Neville, 1995, Mob-1 expression in IL-2-induced ARDS: regulation by TNF-alpha, Am. J. Physiol., 269, L884 Abdullah, 1997, The novel chemokine mob-1: involvement in adult respiratory distress syndrome, Surgery, 122, 303, 10.1016/S0039-6060(97)90022-2 Rabinovici, 2002, MOB-1 and TNF-alpha interact to induce microvascular lung injury, Shock, 18, 261, 10.1097/00024382-200209000-00010 Ichikawa, 2013, CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin, Am. J. Respir. Crit. Care Med., 187, 65, 10.1164/rccm.201203-0508OC Lang, 2017, CXCL10/IP-10 neutralization can ameliorate lipopolysaccharide-induced acute respiratory distress syndrome in rats, PLoS One, 12, 10.1371/journal.pone.0169100 García-Laorden, 2017, Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise, Ann. Transl. Med., 5, 283, 10.21037/atm.2017.06.49 Fremont, 2010, Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis, J. Trauma, 68, 1121, 10.1097/TA.0b013e3181c40728 Calfee, 2011, B.o. National Heart, and Lung Institute Acute Respiratory Distress Syndrome Network, Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury, Crit. Care Med., 39, 711, 10.1097/CCM.0b013e318207ec3c Aisiku, 2016, Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury, Crit Care, 20, 288, 10.1186/s13054-016-1470-7 Agrawal, 2012, Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials, Am. J. Physiol. Lung Cell Mol. Physiol., 303, L634, 10.1152/ajplung.00195.2012 Goodman, 1996, Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome, Am. J. Respir. Crit. Care Med., 154, 602, 10.1164/ajrccm.154.3.8810593 Donnelly, 1993, Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups, Lancet, 341, 643, 10.1016/0140-6736(93)90416-E Miller, 1992, Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality, Am. Rev. Respir. Dis., 146, 427, 10.1164/ajrccm/146.2.427 Folkesson, 1995, Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms, J. Clin. Invest., 96, 107, 10.1172/JCI118009 Bacon, 2002, Chemokine/chemokine receptor nomenclature, J. Interferon Cytokine Res., 22, 1067, 10.1089/107999002760624305 Bachelerie, 2014, International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors, Pharmacol. Rev., 66, 1, 10.1124/pr.113.007724 Tiberio, 2018, Chemokine and chemotactic signals in dendritic cell migration, Cell. Mol. Immunol., 15, 346, 10.1038/s41423-018-0005-3 Ward, 1998, Chemokines and T lymphocytes: more than an attraction, Immunity, 9, 1, 10.1016/S1074-7613(00)80583-X Coperchini, 2019, Role of chemokine receptors in thyroid cancer and immunotherapy, Endocr. Relat. Cancer, 10.1530/ERC-19-0163 Li, 2020, Coronavirus infections and immune responses, J. Med. Virol., 92, 424, 10.1002/jmv.25685 Simmonds, 2018, Virus classification - where do you draw the line?, Arch. Virol., 163, 2037, 10.1007/s00705-018-3938-z Melchjorsen, 2003, Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function, J. Leukoc. Biol., 74, 331, 10.1189/jlb.1102577 Haller, 2006, The interferon response circuit: induction and suppression by pathogenic viruses, Virology, 344, 119, 10.1016/j.virol.2005.09.024 Hertzog, 2003, The interferon in TLR signaling: more than just antiviral, Trends Immunol., 24, 534, 10.1016/j.it.2003.08.006 Le Bon, 2002, Links between innate and adaptive immunity via type I interferon, Curr. Opin. Immunol., 14, 432, 10.1016/S0952-7915(02)00354-0 Weber, 2004, Inverse interference: how viruses fight the interferon system, Viral Immunol., 17, 498, 10.1089/vim.2004.17.498 Hayney, 2017, Serum IFN-γ-induced protein 10 (IP-10) as a biomarker for severity of acute respiratory infection in healthy adults, J. Clin. Virol., 90, 32, 10.1016/j.jcv.2017.03.003 Almansa, 2011, Host response cytokine signatures in viral and nonviral acute exacerbations of chronic obstructive pulmonary disease, J. Interferon Cytokine Res., 31, 409, 10.1089/jir.2010.0131 Quint, 2010, Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD, Chest, 137, 812, 10.1378/chest.09-1541 Küng, 2014, The pneumococcal polysaccharide capsule and pneumolysin differentially affect CXCL8 and IL-6 release from cells of the upper and lower respiratory tract, PLoS One, 9, 10.1371/journal.pone.0092355 Henriquez, 2015, Association of interleukin-8 and neutrophils with nasal symptom severity during acute respiratory infection, J. Med. Virol., 87, 330, 10.1002/jmv.24042 Alcami, 2003, Viral mimicry of cytokines, chemokines and their receptors, Nat. Rev. Immunol., 3, 36, 10.1038/nri980 Thiel, 2008, Interferon and cytokine responses to SARS-coronavirus infection, Cytokine Growth Factor Rev., 19, 121, 10.1016/j.cytogfr.2008.01.001 Peiris, 2003, Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study, Lancet, 361, 1767, 10.1016/S0140-6736(03)13412-5 Wong, 2004, Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome, Clin. Exp. Immunol., 136, 95, 10.1111/j.1365-2249.2004.02415.x Openshaw, 2004, What does the peripheral blood tell you in SARS?, Clin. Exp. Immunol., 136, 11, 10.1111/j.1365-2249.2004.02448.x Huang, 2005, An interferon-gamma-related cytokine storm in SARS patients, J. Med. Virol., 75, 185, 10.1002/jmv.20255 Jiang, 2005, Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome, Am. J. Respir. Crit. Care Med., 171, 850, 10.1164/rccm.200407-857OC Spiegel, 2006, Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells, J. Gen. Virol., 87, 1953, 10.1099/vir.0.81624-0 Law, 2005, Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells, Blood, 106, 2366, 10.1182/blood-2004-10-4166 Lau, 2005, Pathogenesis of severe acute respiratory syndrome, Curr. Opin. Immunol., 17, 404, 10.1016/j.coi.2005.05.009 Reghunathan, 2005, Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome, BMC Immunol., 6, 2, 10.1186/1471-2172-6-2 Chang, 2004, Induction of IL-8 release in lung cells via activator protein-1 by recombinant baculovirus displaying severe acute respiratory syndrome-coronavirus spike proteins: identification of two functional regions, J. Immunol., 173, 7602, 10.4049/jimmunol.173.12.7602 Ng, 2004, A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection, BMC Infect. Dis., 4, 34, 10.1186/1471-2334-4-34 Zhao, 2011, Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice, J. Clin. Invest., 121, 4921, 10.1172/JCI59777 Channappanavar, 2016, Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice, Cell Host Microbe, 19, 181, 10.1016/j.chom.2016.01.007 Kindler, 2016, SARS-CoV and IFN: Too Little, Too Late, Cell Host Microbe, 19, 139, 10.1016/j.chom.2016.01.012 Prentice, 2004, Coronavirus replication complex formation utilizes components of cellular autophagy, J. Biol. Chem., 279, 10136, 10.1074/jbc.M306124200 Snijder, 2006, Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex, J. Virol., 80, 5927, 10.1128/JVI.02501-05 Frieman, 2007, Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane, J. Virol., 81, 9812, 10.1128/JVI.01012-07 Kopecky-Bromberg, 2007, Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists, J. Virol., 81, 548, 10.1128/JVI.01782-06 Leung, 2004, One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers, Cell, 118, 453, 10.1016/j.cell.2004.08.007 Cinatl, 2004, Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus, Cell. Mol. Life Sci., 61, 2100, 10.1007/s00018-004-4222-9 Frieman, 2008, SARS coronavirus and innate immunity, Virus Res., 133, 101, 10.1016/j.virusres.2007.03.015 Spiegel, 2006, Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus, Virol. J., 3, 17, 10.1186/1743-422X-3-17 He, 2003, Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein, Biochem. Biophys. Res. Commun., 311, 870, 10.1016/j.bbrc.2003.10.075 Kim, 2016, Clinical progression and cytokine profiles of middle east respiratory syndrome coronavirus infection, J. Korean Med. Sci., 31, 1717, 10.3346/jkms.2016.31.11.1717 Faure, 2014, Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?, PLoS One, 9, 10.1371/journal.pone.0088716 Lau, 2007, Perfluoroalkyl acids: a review of monitoring and toxicological findings, Toxicol. Sci., 99, 366, 10.1093/toxsci/kfm128 Chu, 2014, Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response, Virology, 454-455, 197, 10.1016/j.virol.2014.02.018 Zhou, 2014, Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis, J. Infect. Dis., 209, 1331, 10.1093/infdis/jit504 Tseng, 2005, Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection, J. Immunol., 174, 7977, 10.4049/jimmunol.174.12.7977 Hao, 2019, The characteristics of hDPP4 transgenic mice subjected to aerosol MERS coronavirus infection via an animal nose-only exposure device, Animal Model Exp. Med., 2, 269, 10.1002/ame2.12088 Chu, 2020, Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19, Clin. Infect. Dis., 10.1093/cid/ciaa410 Chen, 2020, Clinical and immunological features of severe and moderate coronavirus disease 2019, J. Clin. Invest., 130, 2620, 10.1172/JCI137244 Xiong, 2020, Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients, Emerg. Microbes Infect., 9, 761, 10.1080/22221751.2020.1747363 Wang, 2020, The laboratory tests and host immunity of COVID-19 patients with different severity of illness, JCI Insight, 10.1172/jci.insight.137799